Cerebral palsy, The Lancet, vol.363, issue.9421, pp.1619-1631, 2004. ,
DOI : 10.1016/S0140-6736(04)16207-7
Magnetic resonance imaging findings in a population-based cohort of children with cerebral palsy, Developmental Medicine & Child Neurology, vol.51, issue.1, pp.51-90, 2009. ,
DOI : 10.1111/j.1469-8749.2008.03127.x
Clinical and MRI Correlates of Cerebral Palsy, JAMA, vol.296, issue.13, pp.1602-1608, 2006. ,
DOI : 10.1001/jama.296.13.1602
The updated european consensus 2009 on the use of botulinum toxin for children with cerebral palsy, Eur. J. Paediatr. Neurol. EJPN: Off. J. Eur. Paediatr. Neurol. Soc, vol.14, pp.45-66, 2010. ,
Cerebral Palsy, I. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: International consensus statement, Eur. J. Neurol. Off. J. Eur. Fed. Neurol. Soc, pp.17-26, 2010. ,
Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting, Toxins, vol.5, issue.3, pp.524-536, 2013. ,
DOI : 10.3390/toxins5030524
Management of Cerebral Palsy with Botulinum-A Toxin, Journal of Pediatric Orthopaedics, vol.13, issue.4, pp.489-495, 1993. ,
DOI : 10.1097/01241398-199307000-00013
BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY, Developmental Medicine & Child Neurology, vol.26, issue.5, pp.386-396, 1994. ,
DOI : 10.1111/j.1469-8749.1994.tb11864.x
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy, Gait & Posture, vol.11, issue.1, pp.67-79, 2000. ,
DOI : 10.1016/S0966-6362(99)00054-5
European consensus table 2006 on botulinum toxin for children with cerebral palsy, Eur. J. Paediatr. Neurol. EJPN: Off. J. Eur. Paediatr. Neurol. Soc, vol.10, pp.215-225, 2006. ,
Spasticity treatment with botulinum toxins, Journal of Neural Transmission, vol.44, issue.2, pp.607-616, 2008. ,
DOI : 10.1007/s00702-007-0833-2
Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation, Lakartidningen, vol.105, pp.3009-3013, 2008. ,
Torrequebrada-Gimenez, A. Clinical practice guidelines for the treatment of spasticity with botulinum toxin, Revista Neurol, vol.50, pp.685-699, 2010. ,
Leon, I.; et al. Guidelines for the treatment of child spasticity using botulinum toxin, Revista Neurol, vol.de Miguel-, pp.44-303, 2007. ,
Available online: http://www.dgn.org/leitl.shtml (accessed on, 2012. ,
PRACTICE PARAMETER: PHARMACOLOGIC TREATMENT OF SPASTICITY IN CHILDREN AND ADOLESCENTS WITH CEREBRAL PALSY (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY AND THE PRACTICE COMMITTEE OF THE CHILD NEUROLOGY SOCIETY, Neurology, vol.75, issue.7, pp.75-669, 2010. ,
DOI : 10.1212/WNL.0b013e3181ec670b
Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity, Journal of Pediatric Orthopaedics B, vol.14, issue.4, pp.269-273, 2005. ,
DOI : 10.1097/01202412-200507000-00007
Upper limb motion analysis in children with hemiplegic cerebral palsy: proximal kinematic changes after distal botulinum toxin or surgical treatments, Journal of Children's Orthopaedics, vol.5, issue.5, pp.363-370, 2011. ,
DOI : 10.1007/s11832-011-0365-z
Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences, European Journal of Neurology, vol.10, issue.s5, pp.8-88, 2001. ,
DOI : 10.1016/0966-6362(95)01054-8
Goal attainment scaling (GAS) in rehabilitation: a practical guide, Clinical Rehabilitation, vol.23, issue.4, pp.362-370, 2009. ,
DOI : 10.1177/0269215508101742
Maciag-Tymecka, I.; Michalowska-Mrozek, J.; Bonikowski, M ,
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: A randomized, double-blind, placebo-controlled, dose-ranging study, Dev. Med. Child Neurol, pp.44-666, 2002. ,
Dysport Paediatric Limb Spasticity Study Group. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type a treatment for lower-limb spasticity in children with cerebral palsy, Dev. Med. Child Neurol, pp.51-436, 2009. ,
High-or low-technology measurements of energy expenditure in clinical gait analysis? Dev. Med. Child Neurol, pp.41-676, 1999. ,
A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures, European Journal of Neurology, vol.30, issue.s5, pp.75-87, 2001. ,
DOI : 10.1016/0966-6362(95)01054-8
When it comes to botulinum toxin, children and adults are not the same: Multimuscle option for children with cerebral palsy, Movement Disorders, vol.39, issue.11, 2006. ,
DOI : 10.1002/mds.21097
Expert consensus on physical therapist intervention after botulinum toxin a injection for children with cerebral palsy, Pediatr. Phys. Ther. Off. Publ. Sect. Pediatr. Am. Phys. Ther. Assoc, vol.13, pp.122-132, 2001. ,
Evidence-based physical therapy for the management of children with cerebral palsy, Dev. Med. Child Neurol, pp.47-795, 2005. ,
Efficacy of Ankle-Foot Orthoses on Gait of Children with Cerebral Palsy: Systematic Review of Literature, Pediatric Physical Therapy, vol.20, issue.3, pp.207-223, 2008. ,
DOI : 10.1097/PEP.0b013e318181fb34
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE), Cochrane Database Syst. Rev, vol.12, issue.4, 2010. ,
DOI : 10.1002/14651858.CD003469.pub4
Botulinum toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment, Dev. Med. Child Neurol, pp.45-758, 2003. ,
Shriners Hospitals BTX-A Study Group. Comparing botulinum toxin a with casting for treatment of dynamic equinus in children with cerebral palsy, Dev. Med. Child Neurol, pp.47-620, 2005. ,
Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: a retrospective analysis, Developmental Medicine & Child Neurology, vol.42, issue.Suppl. 5, pp.807-811, 2004. ,
DOI : 10.1111/j.1469-8749.2004.tb00445.x
BOTULINUM TOXIN AS AN ADJUNCT TO SERIAL CASTING TREATMENT IN CHILDREN WITH CEREBRAL PALSY, The Journal of Bone and Joint Surgery-American Volume, vol.86, issue.11, p.86, 23772384. ,
DOI : 10.2106/00004623-200411000-00003
The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy, Journal of Bone and Joint Surgery - British Volume, vol.92, issue.8, pp.1152-1159, 2010. ,
DOI : 10.1302/0301-620X.92B8.23086
Short-Term Effects of Combined Serial Casting and Botulinum Toxin Injection for Spastic Equinus in Ambulatory Children with Cerebral Palsy, Yonsei Medical Journal, vol.51, issue.4, pp.51-579, 2010. ,
DOI : 10.3349/ymj.2010.51.4.579
Preoperative botulinum toxin test injections before muscle lengthening in cerebral palsy, Journal of Orthopaedic Science, vol.15, issue.5, pp.647-653, 2010. ,
DOI : 10.1007/s00776-010-1509-6
Short- and long-term effects of selective dorsal rhizotomy on gross motor function in ambulatory children with spastic diplegia, Journal of Neurosurgery: Pediatrics, vol.7, issue.5, pp.557-562, 2011. ,
DOI : 10.3171/2011.2.PEDS10452
Botulinum toxin injection of eye muscles to correct strabismus, Trans. Am. Ophthalmol. Soc, pp.79-734, 1981. ,
Pharmacologic weakening of extraocular muscles, Investig. Ophthalmol, vol.12, pp.924-927, 1973. ,
Clinical value of botulinum toxin in neurological indications, European Journal of Neurology, vol.6, issue.4, pp.13-20, 2006. ,
DOI : 10.1046/j.1468-1331.2001.00040.x
Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome, European Journal of Neurology, vol.46, issue.s5, pp.8-145, 2001. ,
DOI : 10.1067/mpd.2000.108393
Botulinum toxin type A improved ankle function in children with cerebral palsy and dynamic equinus foot deformity, The Journal of Bone and Joint Surgery-American Volume, vol.82, issue.6, 2000. ,
DOI : 10.2106/00004623-200006000-00016
The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial, European Journal of Neurology, vol.33, issue.s5, pp.8-50, 2001. ,
DOI : 10.1016/S0887-8994(97)00164-1
Repeated Botulinum Toxin A Injections in the Treatment of Spastic Equinus Foot, Clinical Orthopaedics and Related Research, vol.394, pp.177-185, 2002. ,
DOI : 10.1097/00003086-200201000-00021
Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy, Archives of Disease in Childhood, vol.83, issue.6, pp.481-487, 2000. ,
DOI : 10.1136/adc.83.6.481
Botulinum Toxin A in the Management of Spastic Gait Disorders in Children and Young Adults with Cerebral Palsy: A Randomized, Double-Blind Study of "High-Dose" versus "Low-Dose" Treatment*, Neuropediatrics, vol.30, issue.03, pp.120-124, 1999. ,
DOI : 10.1055/s-2007-973475
Factors Predicting the Efficacy of Botulinum Toxin-A Treatment of the Lower Limb in Children With Cerebral Palsy, Journal of Child Neurology, vol.16, issue.4, pp.661-666, 2005. ,
DOI : 10.1177/08830738050200080501
Botulinum toxin and cerebral palsy: Time for reflection? Dev, Med. Child Neurol, pp.47-709, 2005. ,
Prevention of dislocation of the hip in children with cerebral palsy. The first ten years of a population-based prevention programme, J. Bone Joint Surg. Br, vol.87, pp.95-101, 2005. ,
Long-term use of botulinum toxin type A in children with cerebral palsy: Treatment consistency, European Journal of Paediatric Neurology, vol.13, issue.5, pp.421-429, 2009. ,
DOI : 10.1016/j.ejpn.2008.07.008
Safety and efficacy of botulinum toxin type A following long-term use, European Journal of Neurology, vol.22, issue.5, pp.13-35, 2006. ,
DOI : 10.1007/s004150050345
High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy, Developmental Medicine & Child Neurology, vol.93, issue.11, pp.49-818, 2007. ,
DOI : 10.1111/j.1469-8749.2007.00818.x
Iatrogenic Botulism Due to Therapeutic Botulinum Toxin A Injection in a Pediatric Patient, Clinical Neuropharmacology, vol.30, issue.5, pp.310-313, 2007. ,
DOI : 10.1097/WNF.0b013e31804b1a0d
Botulinum neurotoxin A: An unusual systemic effect, Journal of Paediatrics and Child Health, vol.10, issue.6, pp.499-501, 2007. ,
DOI : 10.1046/j.1468-1331.2001.00041.x
Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy, Developmental Medicine & Child Neurology, vol.334, issue.Suppl 5, pp.139-144, 2010. ,
DOI : 10.1111/j.1469-8749.2009.03583.x
The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life, International Journal of Rehabilitation Research, vol.33, issue.2, pp.104-108, 2010. ,
DOI : 10.1097/MRR.0b013e32832c1e91
Safety of botulinum toxin a in cerebral palsy, Toxicon: Off. J. Int. Soc. Toxinol, pp.51-52, 2008. ,
Validation of a model of gross motor function for children with cerebral palsy, Phys. Ther, vol.80, pp.974-985, 2000. ,
Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review, Developmental Medicine & Child Neurology, vol.134, issue.3, pp.210-216, 2011. ,
DOI : 10.1111/j.1469-8749.2010.03890.x
Botulinum toxin a in children with infantile cerebral palsy: Indications and treatment concepts. Der, 2010. ,
Development of Treatment Concepts for the Use of Botulinum Toxin A in Children with Cerebral Palsy, Toxins, vol.2, issue.9, pp.2258-2271, 2010. ,
DOI : 10.3390/toxins2092258
A dose???response relationship research on botulinum toxin type A local intramuscular injections of lower extremity spasticity in children with cerebral palsy, Child's Nervous System, vol.83, issue.5, pp.545-547, 2008. ,
DOI : 10.1007/s00381-007-0571-7
Neurophysiological Double-Blind Trial of a Botulinum Neurotoxin Type A Free of Complexing Proteins, Clinical Neuropharmacology, vol.30, issue.2, pp.86-94, 2007. ,
DOI : 10.1097/01.WNF.0000240951.18821.50
The Petö System and Its Evolution in Britain; Acorn Foundation, 1994. ,
Improved scaling of the gross motor function measure for children with cerebral palsy: Evidence of reliability and validity, Phys. Ther, vol.80, pp.873-885, 2000. ,
Assessment of Gross Motor Development in the WHO Multicentre Growth Reference Study, Food and Nutrition Bulletin, vol.25, issue.1, pp.37-45, 2004. ,
DOI : 10.1177/15648265040251S105
Early skill learning is expressed through selection and tuning of cortically represented muscle synergies, J. Neurosci. Off. J. Soc. Neurosci, vol.23, pp.11255-11269, 2003. ,
Central mechanisms of motor skill learning, Current Opinion in Neurobiology, vol.12, issue.2, pp.217-222, 2002. ,
DOI : 10.1016/S0959-4388(02)00307-0
Differences in the Corticospinal Projection from Primary Motor Cortex and Supplementary Motor Area to Macaque Upper Limb Motoneurons: An Anatomical and Electrophysiological Study, Cerebral Cortex, vol.12, issue.3, pp.281-296, 2002. ,
DOI : 10.1093/cercor/12.3.281
Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A, Archives of Physical Medicine and Rehabilitation, vol.86, issue.3, pp.431-435, 2005. ,
DOI : 10.1016/j.apmr.2004.03.034
Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review, Toxins, vol.5, issue.1, pp.60-72, 2013. ,
DOI : 10.3390/toxins5010060
Safety of botulinum toxin type A in children younger than 2 years, European Journal of Paediatric Neurology, vol.13, issue.6, pp.511-515, 2009. ,
DOI : 10.1016/j.ejpn.2008.10.006
Neurologische rehabilitation von kindern mit hirnschä digung im ersten und zweiten lebensjahr?Berliner modell, Praxis Ergotherapie, 2009. ,
Musculoskeletal aspects of cerebral palsy, The Journal of Bone and Joint Surgery, vol.85, issue.2, pp.157-166, 2003. ,
DOI : 10.1302/0301-620X.85B2.14066
Goal attainment scaling in paediatric rehabilitation: a critical review of the literature, Developmental Medicine & Child Neurology, vol.36, issue.7, pp.49-550, 2007. ,
DOI : 10.1111/j.1469-8749.2007.00550.x
The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling, Clinical Rehabilitation, vol.7, issue.5, pp.274-282, 2005. ,
DOI : 10.1191/0269215505cr859oa
Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity, Physical Therapy, vol.67, issue.2, pp.67-206, 1987. ,
DOI : 10.1093/ptj/67.2.206
Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments, Developmental Medicine & Child Neurology, vol.91, issue.01, pp.48-64, 2006. ,
DOI : 10.1111/j.1469-8749.2003.tb00418.x
Evaluation of Spasticity in Children With Cerebral Palsy Using Ashworth and Tardieu Scales Compared With Laboratory Measures, Journal of Child Neurology, vol.25, issue.10, pp.1242-1247, 2010. ,
DOI : 10.1177/0883073810362266
Reliability of the Tardieu Scale for Assessing Spasticity in Children With Cerebral Palsy, Archives of Physical Medicine and Rehabilitation, vol.91, issue.3, pp.91-421, 2010. ,
DOI : 10.1016/j.apmr.2009.11.017
Melbourne assessment of unilateral upper limb function: Construct validity and correlation with the pediatric evaluation of disability inventory, Dev. Med. Child Neurol, pp.45-92, 2003. ,
DEVELOPMENT OF A CLINICAL ASSESSMENT OF QUALITY OF MOVEMENT FOR UNILATERAL UPPER-LIMB FUNCTION, Developmental Medicine & Child Neurology, vol.54, issue.11, pp.965-973, 1994. ,
DOI : 10.1111/j.1469-8749.1994.tb11792.x
The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change, Developmental Medicine & Child Neurology, vol.85, issue.4, pp.49-259, 2007. ,
DOI : 10.1111/j.1469-8749.2007.00259.x
Activities Scale for Kids, Journal of Pediatric Orthopaedics, vol.23, issue.6, pp.788-790, 2003. ,
DOI : 10.1097/01241398-200311000-00018
Quantitative analysis of gait pattern and energy consumption in children with cerebral palsy, J. Appl. Biomater. Biomechan. JABB, vol.5, pp.28-33, 2007. ,
The Combined Effect of Lower-Limb Multilevel Botulinum Toxin Type A and Comprehensive Rehabilitation on Mobility in Children With Cerebral Palsy: A Randomized Clinical Trial, Archives of Physical Medicine and Rehabilitation, vol.87, issue.12, pp.1551-1558, 2006. ,
DOI : 10.1016/j.apmr.2006.08.342
Measuring quality of life in cerebral palsy children, Annales de R??adaptation et de M??decine Physique, vol.51, issue.2 ,
DOI : 10.1016/j.annrmp.2007.12.007
Self-generated Domains of Quality of Life in Children with and Without Cerebral Palsy, Journal of Developmental and Physical Disabilities, vol.42, issue.Suppl. 4, pp.497-508, 2010. ,
DOI : 10.1007/s10882-010-9187-z
Mental health, health related quality of life and recurrent musculoskeletal pain in children with cerebral palsy 8???18 years old, Disability and Rehabilitation, vol.13, issue.2, pp.1589-1595, 2012. ,
DOI : 10.1111/j.1469-8749.2011.04014.x
The association between premature plantarflexor muscle activity, muscle strength, and equinus gait in patients with various pathologies, Research in Developmental Disabilities, vol.34, issue.9, pp.2676-2683, 2013. ,
DOI : 10.1016/j.ridd.2013.05.025
The influence of muscle strength on the gait profile score (GPS) across different patients, Gait & Posture, vol.39, issue.1, 2014. ,
DOI : 10.1016/j.gaitpost.2013.06.001
Respective potencies of Botox?? and Dysport?? in a human skin model: A randomized, double-blind study, Movement Disorders, vol.5, issue.2, pp.231-236, 2009. ,
DOI : 10.1002/mds.22336
Retrospective evaluation of the dose of dysport and botox in the management of cervical dystonia and blepharospasm: The real dose study, Mov. Disord. Off. J. Mov. Disord. Soc, vol.20, pp.937-944, 2005. ,
Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?, Current Medical Research and Opinion, vol.25, issue.7, pp.1573-1584, 2009. ,
DOI : 10.1185/03007990903028203
URL : https://hal.archives-ouvertes.fr/hal-00627967
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease, Neurology, vol.49, issue.3, pp.724-728, 1997. ,
DOI : 10.1212/WNL.49.3.724
Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox), Journal of Biomechanics, vol.44, issue.1, pp.44-83, 2011. ,
DOI : 10.1016/j.jbiomech.2010.08.020
??????????????????A??????????????????????????????????????????????????????, Journal of Zhejiang University-SCIENCE B, vol.16, issue.1, pp.46-51, 2015. ,
DOI : 10.1631/jzus.B1400192
Botulinum Toxin Type a in the Management of Cerebral Palsy, 2002. ,
Accuracy of Intramuscular Injection of Botulinum Toxin A in Juvenile Cerebral Palsy, Journal of Pediatric Orthopaedics, vol.25, issue.3, pp.286-291, 2005. ,
DOI : 10.1097/01.bpo.0000150819.72608.86
Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia, Neurology, vol.58, issue.5, pp.805-807, 2002. ,
DOI : 10.1212/WNL.58.5.805
Ultrasound-guided botulinum toxin injection technique for the iliopsoas muscle, Dev. Med. Child Neurol, pp.45-829, 2003. ,
Technique for Iliopsoas Ultrasound-Guided Active Electromyography-Directed Botulinum A Toxin Injection in Cerebral Palsy, Journal of Pediatric Orthopaedics, vol.22, issue.2, pp.165-168, 2002. ,
DOI : 10.1097/01241398-200203000-00005
Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance, Annals of Physical and Rehabilitation Medicine, vol.52, issue.3, pp.52-215, 2009. ,
DOI : 10.1016/j.rehab.2009.02.005
Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model, Muscle & Nerve, vol.20, issue.5, pp.653-655, 1998. ,
DOI : 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W